These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38767829)

  • 21. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
    Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
    Nitta Y; Tanaka T; Morimoto K; Makino T; Nishikawa N; Tashiro K; Naganuma T; Iguchi T; Matsuoka T; Nakatani T
    Anticancer Res; 2012 Feb; 32(2):615-8. PubMed ID: 22287753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
    Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
    J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
    Cool DW; Kachura JR
    J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.
    Ierardi AM; Puliti A; Angileri SA; Petrillo M; Duka E; Floridi C; Lecchi M; Carrafiello G
    Med Oncol; 2017 May; 34(5):97. PubMed ID: 28421553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
    Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
    Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
    Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
    Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
    Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
    Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
    Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation.
    Wetley KA; Abel EJ; Dreyfuss LD; Huang W; Brace CL; Wells SA
    Abdom Radiol (NY); 2020 Sep; 45(9):2810-2824. PubMed ID: 32715335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.
    Zhang ZL; Chen W; Li YH; Liu ZW; Luo JH; Lau W; Tan MH; Zhou FJ
    Chin J Cancer; 2011 Nov; 30(11):772-8. PubMed ID: 22035858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors.
    Ahrar K; Wallace MJ; Matin SF
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1735-44. PubMed ID: 17181487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventional management of a renal cell carcinoma by radiofrequency ablation with tagging and cooling.
    Mahnken AH; Penzkofer T; Bruners P; Günther RW; Brehmer B
    Korean J Radiol; 2009; 10(5):523-6. PubMed ID: 19721840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.